156 related articles for article (PubMed ID: 36932995)
21. Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression.
Paradis JS; Ly S; Blondel-Tepaz É; Galan JA; Beautrait A; Scott MG; Enslen H; Marullo S; Roux PP; Bouvier M
Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5160-8. PubMed ID: 26324936
[TBL] [Abstract][Full Text] [Related]
22. Enhanced selectivity screening of GPCR ligands using a label-free cell based assay technology.
McGuinness RP; Proctor JM; Gallant DL; van Staden CJ; Ly JT; Tang FL; Lee PH
Comb Chem High Throughput Screen; 2009 Sep; 12(8):812-23. PubMed ID: 19531008
[TBL] [Abstract][Full Text] [Related]
23. Crosstalk coregulation mechanisms of G protein-coupled receptors and receptor tyrosine kinases.
Natarajan K; Berk BC
Methods Mol Biol; 2006; 332():51-77. PubMed ID: 16878685
[TBL] [Abstract][Full Text] [Related]
24. G protein-coupled receptors--recent advances.
Latek D; Modzelewska A; Trzaskowski B; Palczewski K; Filipek S
Acta Biochim Pol; 2012; 59(4):515-29. PubMed ID: 23251911
[TBL] [Abstract][Full Text] [Related]
25. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function.
Kristiansen K
Pharmacol Ther; 2004 Jul; 103(1):21-80. PubMed ID: 15251227
[TBL] [Abstract][Full Text] [Related]
26. Label-free detection of transporter activity via GPCR signalling in living cells: A case for SLC29A1, the equilibrative nucleoside transporter 1.
Vlachodimou A; IJzerman AP; Heitman LH
Sci Rep; 2019 Sep; 9(1):13802. PubMed ID: 31551431
[TBL] [Abstract][Full Text] [Related]
27. Impedance analysis of GPCR-mediated changes in endothelial barrier function: overview and fundamental considerations for stable and reproducible measurements.
Stolwijk JA; Matrougui K; Renken CW; Trebak M
Pflugers Arch; 2015 Oct; 467(10):2193-218. PubMed ID: 25537398
[TBL] [Abstract][Full Text] [Related]
28. G-protein-coupled designer receptors - new chemical-genetic tools for signal transduction research.
Thiel G; Kaufmann A; Rössler OG
Biol Chem; 2013 Dec; 394(12):1615-22. PubMed ID: 23893685
[TBL] [Abstract][Full Text] [Related]
29. Quantitative Measurement of GPCR Endocytosis via Pulse-Chase Covalent Labeling.
Kumagai H; Ikeda Y; Motozawa Y; Fujishiro M; Okamura T; Fujio K; Okazaki H; Nomura S; Takeda N; Harada M; Toko H; Takimoto E; Akazawa H; Morita H; Suzuki J; Yamazaki T; Yamamoto K; Komuro I; Yanagisawa M
PLoS One; 2015; 10(5):e0129394. PubMed ID: 26020647
[TBL] [Abstract][Full Text] [Related]
30. Luciferase Complementation Approaches to Measure GPCR Signaling Kinetics and Bias.
Dijon NC; Nesheva DN; Holliday ND
Methods Mol Biol; 2021; 2268():249-274. PubMed ID: 34085274
[TBL] [Abstract][Full Text] [Related]
31. RGS proteins destroy spare receptors: Effects of GPCR-interacting proteins and signal deamplification on measurements of GPCR agonist potency.
Chidiac P
Methods; 2016 Jan; 92():87-93. PubMed ID: 26297537
[TBL] [Abstract][Full Text] [Related]
32. Label-free whole-cell assays: expanding the scope of GPCR screening.
Scott CW; Peters MF
Drug Discov Today; 2010 Sep; 15(17-18):704-16. PubMed ID: 20601093
[TBL] [Abstract][Full Text] [Related]
33. Dimerization in GPCR mobility and signaling.
Lohse MJ
Curr Opin Pharmacol; 2010 Feb; 10(1):53-8. PubMed ID: 19910252
[TBL] [Abstract][Full Text] [Related]
34. A cAMP Biosensor-Based High-Throughput Screening Assay for Identification of Gs-Coupled GPCR Ligands and Phosphodiesterase Inhibitors.
Vedel L; Bräuner-Osborne H; Mathiesen JM
J Biomol Screen; 2015 Aug; 20(7):849-57. PubMed ID: 25851033
[TBL] [Abstract][Full Text] [Related]
35. Label-free cell-based assays for GPCR screening.
Fang Y; Frutos AG; Verklereen R
Comb Chem High Throughput Screen; 2008 Jun; 11(5):357-69. PubMed ID: 18537557
[TBL] [Abstract][Full Text] [Related]
36. The Ancient Link between G-Protein-Coupled Receptors and C-Terminal Phospholipid Kinase Domains.
van den Hoogen DJ; Meijer HJG; Seidl MF; Govers F
mBio; 2018 Jan; 9(1):. PubMed ID: 29362235
[TBL] [Abstract][Full Text] [Related]
37. Reversible G Protein βγ9 Distribution-Based Assay Reveals Molecular Underpinnings in Subcellular, Single-Cell, and Multicellular GPCR and G Protein Activity.
Senarath K; Ratnayake K; Siripurapu P; Payton JL; Karunarathne A
Anal Chem; 2016 Dec; 88(23):11450-11459. PubMed ID: 27778511
[TBL] [Abstract][Full Text] [Related]
38. Recent progress in assays for GPCR drug discovery.
Guo S; Zhao T; Yun Y; Xie X
Am J Physiol Cell Physiol; 2022 Aug; 323(2):C583-C594. PubMed ID: 35816640
[TBL] [Abstract][Full Text] [Related]
39. Beyond structure: emerging approaches to study GPCR dynamics.
Gusach A; Maslov I; Luginina A; Borshchevskiy V; Mishin A; Cherezov V
Curr Opin Struct Biol; 2020 Aug; 63():18-25. PubMed ID: 32305785
[TBL] [Abstract][Full Text] [Related]
40. Superagonism at G protein-coupled receptors and beyond.
Schrage R; De Min A; Hochheiser K; Kostenis E; Mohr K
Br J Pharmacol; 2016 Oct; 173(20):3018-27. PubMed ID: 26276510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
